ClinicalTrials.Veeva

Menu

Impella Real-World Surveillance of Patients Using Sodium Bicarbonate

Abiomed logo

Abiomed

Status

Completed

Conditions

High Risk PCI
Cardiogenic Shock

Treatments

Device: Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
Device: Impella RP with Sodium Bicarbonate used as purge solution

Study type

Observational

Funder types

Industry

Identifiers

NCT05820451
ABMD-CIP-21-02-SS01

Details and patient eligibility

About

The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.

Enrollment

312 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Left Sided Impella

Inclusion Criteria:

  • Left-sided Impella with bicarbonate in the purge

Exclusion Criteria:

  • Known LV thrombus

Right Sided Impella

Inclusion Criteria:

  • Right-sided Impella with bicarbonate in the purge

Exclusion Criteria:

  • Known pulmonary thromboemboli
  • Known DVT

Trial design

312 participants in 2 patient groups

Left sided device
Description:
All patients implanted with a left sided support Impella device - this includes but is not limited to Impella 2.5, Impella CP, Impella 5.0, Impella 5.5.
Treatment:
Device: Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
Right sided device
Description:
All patients implanted with a right sided support Impella device -this includes the Impella RP
Treatment:
Device: Impella RP with Sodium Bicarbonate used as purge solution

Trial contacts and locations

20

Loading...

Central trial contact

Stacie Hallaway; Oksana Bradley

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems